Skip to main content

Industry insights

Publications

Modified Delphi research to seek consensus on dRTA disease model, treatment and management

Sarah Coyle, Scott Donald, Andrew Mumford, Joanne Mumford

Gaining consensus: the challenges of living with a stoma and the impact of stoma leakage

Miriayi Aibibula, Caroline Bramwell, Gill Burry, Giovanni Cinque, Hannah Gagen, Harry Lewis, Wendy Osborne, Hazel Pixley

Evaluation of the updated French Autorisation d’accès précoce (AAP) Early Access Authorisation pathway

Oliver Darlington, Elise Evers, Sesh Rahim

A Review and Evaluation of Reimbursement Outcomes for Non-orphan and Orphan drugs in Ireland in 2023

Myrtle Greenwood, Sarah Jane Lyttle, Georgia Roberts, Andrew Mumford

A review and evaluation of the UK’s Innovative Licensing and Access Pathway

Myrtle Greenwood, Andrew Mumford, David Ringger, Adelaide Shaw-Maguire

A comparative analysis of the relationship between orphan drug status and reimbursement status in Ireland, Sweden, France, and Canada in 2022

Myrtle Greenwood, Sarah Jane Lyttle, Andrew Mumford, Georgia Roberts

Listen to our podcast: Initiation

Working with Initiate | What to expect working with our market access and health economics consultancy | Initiation Podcast

Developing PROMs in rare diseases | A conversation with Benson Chen from MitoCAMB | Initiation Podcast

Insights from the 2023 Reimbursement Radar wrap-up | Initiation Podcast

View more in Spotify

Events & conferences

We attend a number of major conferences and would love to meet you at the events listed below:

World EPA Congress 2025

5th-6th March 2025

Talks & webinars

As market access and HEOR experts, we are regularly asked to talk at industry events. We’d love to see you in our audience at the following events:

Life Science Access Academy

Value Based Healthcare for Life Sciences Made Simple

Monday 17th March 13:00 – 14:00 (GMT)